References
Ashmarin, I.P., Nezavibat'ko, V.N., Myasoedov, N.F., et al., Zh. Vyssh. Nervn. Deyat., 1997, vol. 47, no. 2, pp. 420-430.
Kaplan, A.Ya., Kochetova, A.G., Nezavibathko, V.N., et al., Neurosci. Res. Commun., 1996, vol. 19, no. 2, pp. 115-123.
Adan, R.A.H., Oosterom, J., and Ludvigsdottir, G., et al., Eur. J. Pharmacol., 1994, vol. 269, pp. 331-337.
Adan, R.A.H. and Gispen, W.H., Peptides, 1997, vol. 18, no. 8, pp. 1279-1287.
Adan, R.A.H. and Gispen, W.H., Eur. J. Pharmacol., 2003, vol. 405, pp. 13-24.
Florijn, W.J., Holtmaat, A.J., de Lang, H., et al., Brain Res., 1993, vol. 625, no. 1, pp. 169-172.
Kudrin, V.S., Sergeeva, S.A., Krasnykh, L.M., et al., Eksp. Klin. Farmakol., 1995, vol. 58, no. 4, pp. 8-11.
Anderzhanova, E.A., Rayevsky, K.S., Saransaari, P., et al., Eur. J. Pharmacol., 2001, vol. 428, pp. 87-95.
Eremin, K.O., Kudrin, V.S., Andreeva, L.A., et al., Neirokhimiya, 2002, vol. 19, no. 4, pp. 269-272.
Chaki, S., Hirota, S., Funakoshi, T., et al., J. Pharm. Exp. Ther., 2003, vol. 304, no. 2, pp. 818-826.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eremin, K.O., Kudrin, V.S., Grivennikov, I.A. et al. Effects of Semax on Dopaminergic and Serotoninergic Systems of the Brain. Doklady Biological Sciences 394, 1–3 (2004). https://doi.org/10.1023/B:DOBS.0000017114.24474.40
Issue Date:
DOI: https://doi.org/10.1023/B:DOBS.0000017114.24474.40